Pfizer names Dr. Chris Boshoff as new Chief Scientific Officer, taking over in January 2025. Pfizer nombra al Dr. Chris Boshoff como nuevo Oficial Científico Jefe, tomando el relevo en enero de 2025.

Pfizer has appointed Chris Boshoff, M.D., PhD, as its new Chief Scientific Officer and President of Research & Development, starting January 1, 2025. Pfizer ha nombrado a Chris Boshoff, M.D., PhD, su nuevo Director Científico y Presidente de Investigación y Desarrollo, a partir del 1 de enero de 2025. Boshoff, who was previously the Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael Dolsten and will report to Pfizer's CEO, Dr. Albert Bourla. Boshoff, que anteriormente era Director de Oncología y Vicepresidente Ejecutivo, sucederá al Dr. Mikael Dolsten e informará al CEO de Pfizer, el Dr. Albert Bourla. In his new role, he will oversee all R&D activities across all therapeutic areas. En su nuevo rol, supervisará todas las actividades de I+D en todas las áreas terapéuticas.